Brainstorm Cell Therapeutics Inc.
BCLI
$0.69
$0.00-0.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -84.49% | -97.02% | -76.25% | 111.04% | -85.62% |
| Total Receivables | 36.51% | 100.00% | 221.21% | 157.69% | 23.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.22% | 171.15% | 86.31% | 36.78% | -75.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.26% | 39.56% | -60.30% | 85.23% | -79.73% |
|
|
|||||
| Total Current Assets | -20.26% | 39.56% | -60.30% | 85.23% | -79.73% |
| Net Property, Plant & Equipment | -64.30% | -57.68% | -50.48% | -45.15% | -40.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -100.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 32.04% | 25.62% | 13.07% | 0.99% | -0.48% |
| Total Assets | -44.21% | -31.85% | -54.85% | 6.66% | -56.46% |
|
|
|||||
| Total Accounts Payable | 16.23% | 39.47% | 12.30% | 44.93% | 22.73% |
| Total Accrued Expenses | -36.03% | -59.54% | -48.89% | -15.41% | -50.08% |
| Short-term Debt | 222.33% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -62.11% | -51.58% | -32.69% | -24.66% | -8.96% |
| Total Finance Division Other Current Liabilities | 65.66% | 79.69% | 57.64% | 109.71% | 42.57% |
| Total Other Current Liabilities | 65.66% | 79.69% | 57.64% | 109.71% | 42.57% |
| Total Current Liabilities | 22.60% | 27.41% | 10.88% | 59.58% | 15.10% |
|
|
|||||
| Total Current Liabilities | 22.60% | 27.41% | 10.88% | 59.58% | 15.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 222.33% | -- | -- | -- | -- |
| Capital Leases | -- | -81.55% | -76.01% | -76.17% | -74.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -24.75% |
| Total Liabilities | 14.70% | 12.26% | -6.37% | 23.94% | 5.85% |
|
|
|||||
| Common Stock & APIC | 3.69% | 4.23% | 4.10% | 4.31% | 4.15% |
| Retained Earnings | -4.55% | -4.85% | -5.18% | -5.08% | -5.41% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -28.61% | -27.01% | -71.73% | -34.36% | -59.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.61% | -27.01% | -71.73% | -34.36% | -59.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.61% | -27.01% | -71.73% | -34.36% | -59.82% |
|
|
|||||